Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Koea

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
JAMA Oncology|October 3, 2024
Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENsJonathan M Loree, David Chan, Jennifer Lim, et al.
ANZ Journal of Surgery|July 7, 2023
Weekend effect in emergency laparotomy: a propensity score-matched analysisAmy Sylivris, Dhruvesh M Ramson, Jahan C Penny-Dimri, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 22, 2020
Pancreatic grade 3 neuroendocrine tumors behave similarly to neuroendocrine carcinomas following resection: a multi-center, international appraisal of the WHO 2010 and WHO 2017 staging schema for pancreatic neuroendocrine lesionsPatrick J Worth, Julie Leal, Qian Ding, et al.
Surgery|May 16, 2022
Clinical features and postoperative survival in patients with sporadic versus multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: An international cohort studyJohn R Bergquist, Omair A Shariq, Amy Y Li, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 17, 2023
A core set of quality performance indicators for HPB procedures: a global consensus for hepatectomy, pancreatectomy, and complex biliary surgeryBraden Woodhouse, Savio G Barreto, Kjetil Soreide, et al.
NPJ Genomic Medicine|August 1, 2018
Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancerBen Lawrence, Cherie Blenkiron, Kate Parker, et al.
The British Journal of Surgery|April 25, 2024
Adjuvant chemotherapy for adenocarcinoma arising from intraductal papillary mucinous neoplasia: multicentre ADENO-IPMN studyJames Lucocq, Jake Hawkyard, Beate Haugk, et al.
Annals of Surgical Oncology|July 3, 2024
Precursor Epithelial Subtypes of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasms (A-IPMN): Clinicopathological Features, Recurrence and Response to Adjuvant ChemotherapyJames Lucocq, Beate Haugk, Daniel Parkinson, et al.
Annals of Surgery|September 25, 2025
Anticoagulation Practice and Risk of Portal Vein Thrombosis Following Pancreaticoduodenectomy or Total Pancreatectomy with Venous Resection: An International Multicentre Cohort StudyPeter L Labib, Siobhan C McKay, Stéphanie F Perrodin, et al.
Annals of Surgery|October 24, 2023
Risk of Recurrence After Surgical Resection for Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasia (IPMN) With Patterns of Distribution and Treatment: An International, Multicenter, Observational Study (ADENO-IPMN Study)James Lucocq, Jake Hawkyard, Francis P Robertson, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
JAMA Oncology|October 3, 2024
Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENsJonathan M Loree, David Chan, Jennifer Lim, et al.
ANZ Journal of Surgery|July 7, 2023
Weekend effect in emergency laparotomy: a propensity score-matched analysisAmy Sylivris, Dhruvesh M Ramson, Jahan C Penny-Dimri, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 22, 2020
Pancreatic grade 3 neuroendocrine tumors behave similarly to neuroendocrine carcinomas following resection: a multi-center, international appraisal of the WHO 2010 and WHO 2017 staging schema for pancreatic neuroendocrine lesionsPatrick J Worth, Julie Leal, Qian Ding, et al.
Surgery|May 16, 2022
Clinical features and postoperative survival in patients with sporadic versus multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: An international cohort studyJohn R Bergquist, Omair A Shariq, Amy Y Li, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 17, 2023
A core set of quality performance indicators for HPB procedures: a global consensus for hepatectomy, pancreatectomy, and complex biliary surgeryBraden Woodhouse, Savio G Barreto, Kjetil Soreide, et al.
NPJ Genomic Medicine|August 1, 2018
Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancerBen Lawrence, Cherie Blenkiron, Kate Parker, et al.
The British Journal of Surgery|April 25, 2024
Adjuvant chemotherapy for adenocarcinoma arising from intraductal papillary mucinous neoplasia: multicentre ADENO-IPMN studyJames Lucocq, Jake Hawkyard, Beate Haugk, et al.
Annals of Surgical Oncology|July 3, 2024
Precursor Epithelial Subtypes of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasms (A-IPMN): Clinicopathological Features, Recurrence and Response to Adjuvant ChemotherapyJames Lucocq, Beate Haugk, Daniel Parkinson, et al.
Annals of Surgery|September 25, 2025
Anticoagulation Practice and Risk of Portal Vein Thrombosis Following Pancreaticoduodenectomy or Total Pancreatectomy with Venous Resection: An International Multicentre Cohort StudyPeter L Labib, Siobhan C McKay, Stéphanie F Perrodin, et al.
Annals of Surgery|October 24, 2023
Risk of Recurrence After Surgical Resection for Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasia (IPMN) With Patterns of Distribution and Treatment: An International, Multicenter, Observational Study (ADENO-IPMN Study)James Lucocq, Jake Hawkyard, Francis P Robertson, et al.
Pageof 13